Multislice CT angiography should be the preferred choice over MR angiography or duplex ultrasound for initial evaluation of patients with suspected peripheral arterial disease.
Multislice CT angiography should be the preferred choice over MR angiography or duplex ultrasound for initial evaluation of patients with suspected peripheral arterial disease.
Dr. Rody Ouwendijk of the Erasmus University Medical Center in Rotterdam, the Netherlands, drew this conclusion from a four-hospital study involving 514 patients with arteriosclerosis in their lower limbs. Patients were randomly selected to receive CTA, MRA, and duplex ultrasound. The clinical and financial effects of the studies were evaluated six months later.
Results, published in the May American Journal of Roentgenology (2008:190:1349-1357), indicate that CTA and MRA were relatively equivalent to one another clinically and demonstrably better than duplex ultrasound.
At an average cost of €104 per procedure, duplex ultrasound was less expensive than CTA (€163) or MRA (€472).
The advantage shifted to CTA and MRA, however, when vascular radiologists and surgeons surveyed for the study had significantly more therapeutic confidence in those two modalities than duplex ultrasound. Within 60 days after initial testing, more additional vascular imaging tests were performed on the patients who had received duplex ultrasound first than on patients who were evaluated with CTA or MRA.
No significant differences were seen in the number of additional tests for patients in the CTA and MRA groups or for quality-of-life measures for patients evaluated with any of the three modalities.
The potential for saving money with CTA led Ouwendijk and colleagues to recommend that modality, considering that its clinical performance was about the same as MRA and demonstrably better than duplex ultrasound.
The main disadvantages of CTA, established in the published medical literature, are patient exposure to ionizing radiation, the use of potentially nephrotoxic iodinated contrast media, and the confounding effects of vessel wall calcifications on image intrepretation.
For more information from the Diagnostic Imaging archives:
MR angiography illustrates runoff in diabetic patients
CTA revolutionizes treatment of peripheral vascular disease
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.